Clinical Trials - GLMD

NCT IDTitleStatusPhasesStart DateCompletion DatePrimary Completion Date
NCT06095986A Study Evaluating the Safety, Tolerability, and Efficacy of Aramchol Meglumine in Primary Sclerosing CholangitisWITHDRAWNPHASE22025-062027-122026-09
NCT06502561Comparing The PK Of Aramchol Meglumine Granules To Aramchol Free Acid TabletsACTIVE_NOT_RECRUITINGPHASE12025-02-152025-052025-05
NCT05857215A First-in-Human Study of Single and Multiple Doses of Amilo-5MER in Healthy SubjectsCOMPLETEDPHASE12021-03-052021-07-012021-07-01
NCT05874336An Open-Label, Two-Part Study Designed to Assess the Absolute Bioavailability and Mass Balance of AramcholCOMPLETEDPHASE12020-06-172020-08-112020-08-11
NCT04480827Open-Label Study to Evaluate the Safety, Tolerability, and PK of Aramchol in Subjects With Hepatic ImpairmentCOMPLETEDPHASE12020-02-132022-03-242022-03-24
NCT04104321A Clinical Study to Evaluate the Efficacy and Safety of Aramchol in Subjects With NASH (ARMOR)SUSPENDEDPHASE32019-09-232027-06-302022-12-08
NCT03774173Comparison of Aramchol Concentrations With Once or Twice Daily DosingCOMPLETEDPHASE12018-12-082019-03-052019-02-03
NCT03760848Study of Potential for Drug Interactions Mediated by CYP3A4 Inhibition With Aramchol in Healthy VolunteersCOMPLETEDPHASE12018-11-122019-02-022019-02-02
NCT02803996Pharmacokinetics of Single and Multiple Escalating Doses of Aramchol Administered Under Fed Conditions in Healthy Chinese VolunteersCOMPLETEDPHASE12016-052016-122016-09
NCT02279524A Clinical Trial to Evaluate the Efficacy and Safety of Two Aramchol Doses Versus Placebo in Patients With NASHCOMPLETEDPHASE22015-04-292018-05-222018-05-22
NCT02325492Medical Dissolution of Cholesterol Gallstones Using Oral Aramchol - A Proof of Concept Phase IIa StudyTERMINATEDPHASE22014-102015-102015-10
NCT02374437Pharmacokinetics of Single and Multiple Escalating Doses of Aramchol and Food Effect in Healthy VolunteersCOMPLETEDPHASE12014-042014-122014-12